PIP5K1α is Required for Promoting Tumor Progression in Castration-Resistant Prostate Cancer

PIP5K1α has emerged as a promising drug target for the treatment of castration-resistant prostate cancer (CRPC), as it acts upstream of the PI3K/AKT signaling pathway to promote prostate cancer (PCa) growth, survival and invasion. However, little is known of the molecular actions of PIP5K1α in this...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tianyan, Sarwar, Martuza, Whitchurch, Jonathan B, Collins, Hilary M, Green, Tami, Semenas, Julius, Ali, Amjad, Roberts, Christopher J, Morris, Ryan D, Hubert, Madlen, Chen, Sa, El-Schich, Zahra, Wingren, Anette G, Grundström, Thomas, Lundmark, Richard, Mongan, Nigel P, Gunhaga, Lena, Heery, David M, Persson, Jenny L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979106/
https://www.ncbi.nlm.nih.gov/pubmed/35386201
http://dx.doi.org/10.3389/fcell.2022.798590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979106/
https://www.ncbi.nlm.nih.gov/pubmed/35386201
http://dx.doi.org/10.3389/fcell.2022.798590

Ejemplares similares